Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight: Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1761 - 1770 of 1957 results

First page
Previous page
Next page
Next page

TISAGENLECLEUCEL

Q6C9WHR03O

Status:

US Approved Rx (2017)

Source:

BLA125646

(2017)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 2017

Source:

BLA125646

Source URL:

https://www.fda.gov/media/113210/download

Class:

STRUCTURALLY DIVERSE

PORK COLLAGEN

I8442U2G7J

Status:

US Approved Rx (2016)

Source:

BLA125603

(2016)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2016

Source:

BLA125603

Source URL:

https://purplebooksearch.fda.gov/

Class:

STRUCTURALLY DIVERSE

VIBRIO CHOLERAE CVD 103-HGR STRAIN LIVE ANTIGEN

V9G528E9E0

Status:

US Approved Rx (2016)

Source:

BLA125597

(2016)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2016

Source:

BLA125597

Source URL:

https://purplebooksearch.fda.gov/

Class:

STRUCTURALLY DIVERSE

ANTHRAX IMMUNE GLOBULIN HUMAN

VKZ83S945Z

Status:

US Approved Rx (2015)

Source:

BLA125562

(2015)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2015

Source:

BLA125562

Source URL:

https://purplebooksearch.fda.gov/

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

MZ5G0F0SAN

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2015

Source:

BLA125510

Source URL:

https://purplebooksearch.fda.gov/

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

OES3CXI7E9

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2015

Source:

BLA125510

Source URL:

https://purplebooksearch.fda.gov/

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

9YRA9J0KI2

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2015

Source:

BLA125510

Source URL:

https://purplebooksearch.fda.gov/

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

QK2T47EPI1

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2015

Source:

BLA125510

Source URL:

https://purplebooksearch.fda.gov/

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

K329YCD1N9

Status:

US Approved Rx (2015)

Source:

BLA125510

(2015)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2015

Source:

BLA125510

Source URL:

https://purplebooksearch.fda.gov/

Class:

STRUCTURALLY DIVERSE

EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2

LE3J6I6DXP

Status:

US Approved Rx (2013)

Source:

BLA125462

(2013)

Source URL:

https://purplebooksearch.fda.gov/

First approved in 2013

Source:

BLA125462

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f3c4292-8773-4781-8264-d71c80d3eabd

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

TISAGENLECLEUCEL

Structurally Diverse

Structurally Diverse

VIBRIO CHOLERAE CVD 103-HGR STRAIN LIVE ANTIGEN

Structurally Diverse

ANTHRAX IMMUNE GLOBULIN HUMAN

Structurally Diverse

INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)

Structurally Diverse

EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2

Showing 1761 - 1770 of 1957 results

First page
Previous page
Next page
Next page

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1